Trastunix
Trastunix 440 mg injection is a HER2/neu receptor antagonist indicated for the treatment of HER2 overexpressing breast cancer and the treatment of HER2-overexpressing metastatic gastric or gastroesophageal junction adenocarcinoma
Features
| Product Name | Trastunix |
| Generic Name | Trastuzumab |
| Therapeutic Class | Monoclonal antibody |
| Formulation | Lyophilized Powder for Injection |
| Available Pack Size | 1x1 |
| Available Strength | 440 mg |